ARCHIVES

FDA, NCI Seek Compromise On Survival Endpoints

This article is from The Cancer Letter archive.

Vol. 15 No. 24 | June 16, 1989

Download PDF Visit The Full Archive

Related Articles

O’Neill Recounts Private Meeting To Increase Cancer Appropriations

May 3, 1991

New Therapeutic Options Enhance Breast Cancer Treatment: ASCO Reports

July 26, 2002

Center Review By Panel, NCI Leading To Changes; Hammer Tells NCAB It Faces “Difficult Decision”

December 13, 1984

In Brief: Selection Of NCI Director Extended By Month; Fisher Named NSABP Scientific Director

March 17, 1995

NCCN Guidelines Retain Avastin For Breast Cancer

October 22, 2010

Rauscher Summarizes Criticism of Cooperative Groups; Changes To Await May 22024 Conference

May 9, 1975